JP2018500883A5 - - Google Patents

Info

Publication number

JP2018500883A5

JP2018500883A5 JP2017525046A JP2017525046A JP2018500883A5 JP 2018500883 A5 JP2018500883 A5 JP 2018500883A5 JP 2017525046 A JP2017525046 A JP 2017525046A JP 2017525046 A JP2017525046 A JP 2017525046A JP 2018500883 A5 JP2018500883 A5 JP 2018500883A5

Authority

JP

Japan

Prior art keywords

antibody

amino acid

acid sequence

seq

hvr

Prior art date

2015-11-10

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 125000003275 alpha amino acid group Chemical group 0.000 claims 56
• 239000005557 antagonist Substances 0.000 claims 32
• 239000003814 drug Substances 0.000 claims 23
• 102000017761 Interleukin-33 Human genes 0.000 claims 22
• 108010067003 Interleukin-33 Proteins 0.000 claims 22
• 102000003816 Interleukin-13 Human genes 0.000 claims 11
• 108090000176 Interleukin-13 Proteins 0.000 claims 11
• 210000004027 cell Anatomy 0.000 claims 11
• 239000000203 mixture Substances 0.000 claims 11
• 206010064930 age-related macular degeneration Diseases 0.000 claims 10
• 102000013691 Interleukin-17 Human genes 0.000 claims 8
• 108050003558 Interleukin-17 Proteins 0.000 claims 8
• 102000000743 Interleukin-5 Human genes 0.000 claims 8
• 108010002616 Interleukin-5 Proteins 0.000 claims 8
• 229940100602 interleukin-5 Drugs 0.000 claims 8
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 7
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 7
• 239000012634 fragment Substances 0.000 claims 7
• 230000035772 mutation Effects 0.000 claims 7
• 239000000427 antigen Substances 0.000 claims 6
• 102000036639 antigens Human genes 0.000 claims 6
• 108091007433 antigens Proteins 0.000 claims 6
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
• 208000035475 disorder Diseases 0.000 claims 6
• 206010010741 Conjunctivitis Diseases 0.000 claims 5
• 101000998137 Homo sapiens Interleukin-33 Proteins 0.000 claims 5
• 102000045906 human IL33 Human genes 0.000 claims 5
• 239000008194 pharmaceutical composition Substances 0.000 claims 5
• 238000000034 method Methods 0.000 claims 4
• 102000005962 receptors Human genes 0.000 claims 4
• 108020003175 receptors Proteins 0.000 claims 4
• 206010012688 Diabetic retinal oedema Diseases 0.000 claims 3
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 3
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 3
• 208000017442 Retinal disease Diseases 0.000 claims 3
• 206010038923 Retinopathy Diseases 0.000 claims 3
• 201000011190 diabetic macular edema Diseases 0.000 claims 3
• 208000015181 infectious disease Diseases 0.000 claims 3
• 238000006467 substitution reaction Methods 0.000 claims 3
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
• 102000011652 Formyl peptide receptors Human genes 0.000 claims 2
• 108010076288 Formyl peptide receptors Proteins 0.000 claims 2
• 208000008069 Geographic Atrophy Diseases 0.000 claims 2
• 210000004241 Th2 cell Anatomy 0.000 claims 2
• 108091008605 VEGF receptors Proteins 0.000 claims 2
• 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 claims 2
• 239000001963 growth medium Substances 0.000 claims 2
• 230000002458 infectious effect Effects 0.000 claims 2
• 230000002401 inhibitory effect Effects 0.000 claims 2
• 210000004962 mammalian cell Anatomy 0.000 claims 2
• 230000001404 mediated effect Effects 0.000 claims 2
• 150000007523 nucleic acids Chemical class 0.000 claims 2
• 102000039446 nucleic acids Human genes 0.000 claims 2
• 108020004707 nucleic acids Proteins 0.000 claims 2
• 210000001236 prokaryotic cell Anatomy 0.000 claims 2
• 208000009137 Behcet syndrome Diseases 0.000 claims 1
• 206010007747 Cataract congenital Diseases 0.000 claims 1
• 206010010744 Conjunctivitis allergic Diseases 0.000 claims 1
• 241000699802 Cricetulus griseus Species 0.000 claims 1
• 206010012689 Diabetic retinopathy Diseases 0.000 claims 1
• 208000003556 Dry Eye Syndromes Diseases 0.000 claims 1
• 208000027004 Eosinophilic disease Diseases 0.000 claims 1
• 241000588724 Escherichia coli Species 0.000 claims 1
• 208000010412 Glaucoma Diseases 0.000 claims 1
• 101000997835 Homo sapiens Tyrosine-protein kinase JAK1 Proteins 0.000 claims 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims 1
• 108010050904 Interferons Proteins 0.000 claims 1
• 102000014150 Interferons Human genes 0.000 claims 1
• 102000004388 Interleukin-4 Human genes 0.000 claims 1
• 108090000978 Interleukin-4 Proteins 0.000 claims 1
• 108090000581 Leukemia inhibitory factor Proteins 0.000 claims 1
• 102100032352 Leukemia inhibitory factor Human genes 0.000 claims 1
• 241000282567 Macaca fascicularis Species 0.000 claims 1
• 101100011750 Mus musculus Hsp90b1 gene Proteins 0.000 claims 1
• 206010028980 Neoplasm Diseases 0.000 claims 1
• 208000002193 Pain Diseases 0.000 claims 1
• 206010038848 Retinal detachment Diseases 0.000 claims 1
• 208000007014 Retinitis pigmentosa Diseases 0.000 claims 1
• 208000027073 Stargardt disease Diseases 0.000 claims 1
• 102100033438 Tyrosine-protein kinase JAK1 Human genes 0.000 claims 1
• 206010046851 Uveitis Diseases 0.000 claims 1
• 208000002205 allergic conjunctivitis Diseases 0.000 claims 1
• 125000000539 amino acid group Chemical group 0.000 claims 1
• 210000000576 arachnoid Anatomy 0.000 claims 1
• 238000003556 assay Methods 0.000 claims 1
• 208000024998 atopic conjunctivitis Diseases 0.000 claims 1
• 210000000741 bile canaliculi Anatomy 0.000 claims 1
• 230000000903 blocking effect Effects 0.000 claims 1
• 208000015114 central nervous system disease Diseases 0.000 claims 1
• 238000012258 culturing Methods 0.000 claims 1
• 239000003085 diluting agent Substances 0.000 claims 1
• 239000003937 drug carrier Substances 0.000 claims 1
• 231100000040 eye damage Toxicity 0.000 claims 1
• 230000003176 fibrotic effect Effects 0.000 claims 1
• 208000026278 immune system disease Diseases 0.000 claims 1
• 230000004968 inflammatory condition Effects 0.000 claims 1
• 230000005764 inhibitory process Effects 0.000 claims 1
• 208000014674 injury Diseases 0.000 claims 1
• 229940079322 interferon Drugs 0.000 claims 1
• 229940028885 interleukin-4 Drugs 0.000 claims 1
• 238000007918 intramuscular administration Methods 0.000 claims 1
• 238000007912 intraperitoneal administration Methods 0.000 claims 1
• 238000001990 intravenous administration Methods 0.000 claims 1
• 238000007914 intraventricular administration Methods 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 210000001672 ovary Anatomy 0.000 claims 1
• 239000000546 pharmaceutical excipient Substances 0.000 claims 1
• 230000004264 retinal detachment Effects 0.000 claims 1
• 230000001568 sexual effect Effects 0.000 claims 1
• 238000002560 therapeutic procedure Methods 0.000 claims 1
• 230000000699 topical effect Effects 0.000 claims 1
• 101150117196 tra-1 gene Proteins 0.000 claims 1
• 230000008733 trauma Effects 0.000 claims 1